Logo image of ALNXT.PA

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

EPA:ALNXT - FR0004171346 - Common Stock

0.497 EUR
+0 (+0.2%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALNXT. ALNXT was compared to 73 industry peers in the IT Services industry. The financial health of ALNXT is average, but there are quite some concerns on its profitability. ALNXT is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.
In the past year ALNXT had a positive cash flow from operations.
ALNXT had positive earnings in each of the past 5 years.
ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

ALNXT has a Return On Assets of 2.48%. This is comparable to the rest of the industry: ALNXT outperforms 41.10% of its industry peers.
With a Return On Equity value of 4.95%, ALNXT perfoms like the industry average, outperforming 41.10% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.08%, ALNXT is in line with its industry, outperforming 41.10% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALNXT is significantly below the industry average of 11.37%.
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROIC 6.08%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

Looking at the Profit Margin, with a value of 2.35%, ALNXT is in line with its industry, outperforming 42.47% of the companies in the same industry.
In the last couple of years the Profit Margin of ALNXT has declined.
With a Operating Margin value of 4.77%, ALNXT perfoms like the industry average, outperforming 45.21% of the companies in the same industry.
In the last couple of years the Operating Margin of ALNXT has declined.
With a Gross Margin value of 55.35%, ALNXT perfoms like the industry average, outperforming 45.21% of the companies in the same industry.
ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALNXT is destroying value.
The number of shares outstanding for ALNXT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALNXT has more shares outstanding
ALNXT has a better debt/assets ratio than last year.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALNXT has an Altman-Z score of 1.93. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
ALNXT's Altman-Z score of 1.93 is on the low side compared to the rest of the industry. ALNXT is outperformed by 60.27% of its industry peers.
ALNXT has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as ALNXT would need 2.63 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.63, ALNXT is in the better half of the industry, outperforming 68.49% of the companies in the same industry.
ALNXT has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALNXT (0.15) is better than 79.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Altman-Z 1.93
ROIC/WACC0.91
WACC6.65%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.18 indicates that ALNXT should not have too much problems paying its short term obligations.
ALNXT has a Current ratio (1.18) which is in line with its industry peers.
A Quick Ratio of 1.18 indicates that ALNXT should not have too much problems paying its short term obligations.
ALNXT has a Quick ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 216.26% over the past year.
Measured over the past 5 years, ALNXT shows a small growth in Earnings Per Share. The EPS has been growing by 3.66% on average per year.
Looking at the last year, ALNXT shows a small growth in Revenue. The Revenue has grown by 6.76% in the last year.
ALNXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.48% yearly.
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%

3.2 Future

Based on estimates for the next years, ALNXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.47% on average per year.
ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.42, ALNXT is valued correctly.
78.08% of the companies in the same industry are more expensive than ALNXT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.03. ALNXT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.33, which indicates a rather cheap valuation of ALNXT.
94.52% of the companies in the same industry are more expensive than ALNXT, based on the Price/Forward Earnings ratio.
ALNXT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.63.
Industry RankSector Rank
PE 12.43
Fwd PE 5.33
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALNXT is valued a bit cheaper than 78.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.65
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.6
PEG (5Y)3.39
EPS Next 2Y9.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALNXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEXTEDIA

EPA:ALNXT (9/4/2025, 7:00:00 PM)

0.497

+0 (+0.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap19.39M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.43
Fwd PE 5.33
P/S 0.3
P/FCF 7.65
P/OCF 7.44
P/B 0.63
P/tB 44.88
EV/EBITDA N/A
EPS(TTM)0.04
EY8.05%
EPS(NY)0.09
Fwd EY18.78%
FCF(TTM)0.06
FCFY13.07%
OCF(TTM)0.07
OCFY13.43%
SpS1.66
BVpS0.79
TBVpS0.01
PEG (NY)0.6
PEG (5Y)3.39
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROCE 8.55%
ROIC 6.08%
ROICexc 8.32%
ROICexgc N/A
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
FCFM 3.92%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 166.85%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.93
F-Score7
WACC6.65%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.78%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.05%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y79.43%
OCF growth 3Y-10.82%
OCF growth 5YN/A